Influenza News and Research

Latest Influenza News and Research

Scientists reveal most likely order of COVID-19 symptoms

Now, a team of researchers at the University of Southern California (USC) has revealed the order of symptoms often experienced by those who infected with SARS-CoV-2. Knowing the order of the symptoms may help the patients seek medical help immediately. The research is published in the journal Frontiers in Public Health.

16 Aug 2020

U.S. scientists to create coronavirus strain for human challenge trials

Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.

16 Aug 2020

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).

14 Aug 2020

COVID-19 pandemic as severe as 1918 influenza pandemic

A recent study published in the journal JAMA Network Open reveals that the excess death toll observed during the initial period of coronavirus disease 2019 (COVID-19) pandemic in New York City is comparable to that observed during the peak of the H1N1 influenza pandemic in 1918.

14 Aug 2020

Preliminary Mayo Clinic results from convalescent plasma in 35,322 patients

A new study published on the preprint server bioRxiv* in August 2020 reports the preliminary results of the US Expanded Access Program (EAP) for CP. The EAP aimed to facilitate access to CP as well as to evaluate the safety of this therapy. However, the current study reports the results of an initial assessment of this agent.

14 Aug 2020

New research finds mHealth technologies as a viable option to monitor COVID-19 patients

An international task force, including two University of Massachusetts Amherst computer scientists, concludes in new research that mobile health (mHealth) technologies are a viable option to monitor COVID-19 patients at home and predict which ones will need medical intervention.

13 Aug 2020

USC researchers find the likely order of COVID-19's symptoms

USC researchers have found the likely order in which COVID-19 symptoms first appear: fever, cough, muscle pain, and then nausea, and/or vomiting, and diarrhea.

13 Aug 2020

Early cases of COVID-19 are far more widespread than initially reported

Patients with undiagnosed flu symptoms who actually had COVID-19 last winter were among thousands of undetected early cases of the disease at the beginning of this year.

13 Aug 2020

Why you should get your flu shots amid the coronavirus pandemic

Health experts from the National Public Health Organization, the Andreas Sygros Hospital, and the Kapodistrian University in Greece say that influenza shots to reduce the risk of flu are crucial, particularly this coming fall or winter when the flu season usually kick starts. Their work is published in the journal Vaccine.

12 Aug 2020

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Researchers at Michigan Tech, TÜV SÜD UK National Engineering Laboratory and University of Edinburgh call for increased research on virus surface stability and interaction in "Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in Variety of Environmental Conditions" in the Cell Press journal Chem.

12 Aug 2020

Real-life discussions may help counter anti-vaccination influences from social media

The flu vaccine is considered one of the great achievements in public health, and each year it prevents millions of people from getting sick and thousands of deaths.

10 Aug 2020

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

A recent case study published in the Journal of Applied Laboratory Medicine in August 2020 illustrates this with its finding of persistent seronegativity in a patient confirmed to be SARS-CoV-2 positive.

10 Aug 2020

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

A new study by researchers from the Scripps Research Institute and Novavax Inc. in the US affirms the structural integrity of the full-length SARS-CoV-2 spike glycoprotein immunogen. It enables the interpretation of immune responses to this multivalent nanoparticle immunogen. Their results are currently available on bioRxiv preprint server.

9 Aug 2020

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

NVX-CoV2373, a recombinant nanoparticle vaccine developed by Novavax and manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic – inducing T-cell response and neutralization antibodies four-fold higher than the mean observed in hospitalized coronavirus disease (COVID-19) patients, shows a recent study available on the medRxiv* preprint server.

9 Aug 2020

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

In a new study in Cell Discovery, Chen-Yu Zhang's group at Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing present a novel finding that absorbed miRNA MIR2911 in honeysuckle decoction (HD) can directly target SARS-CoV-2 genes and inhibit viral replication. Drinking of HD accelerate the negative conversion of COVID-19 patients.

7 Aug 2020

Humans promote diseases from the animal kingdom

The coronavirus pandemic, which has now infected nearly 19 million and killed more than 712,000 people, most likely originated from bats. Just like other coronavirus outbreaks in the past, a spill-over event or zoonosis caused the viruses to jump from animals to humans.

6 Aug 2020

Study shows recombination among SARS-CoV-2 strains is already occurring, but remains rare

A recent study by U.S. researchers, currently available on the bioRxiv preprint server, indicates that the recombination events among the viral strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are already occurring – however, considering current levels of viral genetic diversity, they are neither widespread nor readily detectable.

6 Aug 2020

America’s obesity epidemic threatens effectiveness of any COVID vaccine

For a world crippled by the coronavirus, salvation hinges on a vaccine.

6 Aug 2020

Eosinophils contribute to antiviral host defense mechanisms during influenza

Eosinophils residing in the airways of mice respond to influenza A virus infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses, according to research published in the Journal of Leukocyte Biology by researchers from Le Bonheur Children's Hospital and the University of Tennessee Health Science Center.

5 Aug 2020

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

In a heated exchange late last month on CNN's State of the Union, host Jake Tapper pressed Adm. Brett Giroir, the Health and Human Services assistant secretary who oversees COVID testing efforts for the Trump administration, on why the government isn't requiring commercial labs to increase testing capacity in order to speed turnaround time.

5 Aug 2020

Influenza News and Research

Latest Influenza News and Research

Scientists reveal most likely order of COVID-19 symptoms

U.S. scientists to create coronavirus strain for human challenge trials

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

COVID-19 pandemic as severe as 1918 influenza pandemic

Preliminary Mayo Clinic results from convalescent plasma in 35,322 patients

New research finds mHealth technologies as a viable option to monitor COVID-19 patients

USC researchers find the likely order of COVID-19's symptoms

Early cases of COVID-19 are far more widespread than initially reported

Why you should get your flu shots amid the coronavirus pandemic

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Real-life discussions may help counter anti-vaccination influences from social media

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Humans promote diseases from the animal kingdom

Study shows recombination among SARS-CoV-2 strains is already occurring, but remains rare

America’s obesity epidemic threatens effectiveness of any COVID vaccine

Eosinophils contribute to antiviral host defense mechanisms during influenza

Could labs that test livestock ease covid testing backlog for people? Well … maybe.

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in